Tags

Type your tag names separated by a space and hit enter

Influenza vaccination for patients with chronic obstructive pulmonary disease: Implications for pharmacists.
Res Social Adm Pharm 2018; 14(2):162-169RS

Abstract

BACKGROUND

Influenza virus is responsible for substantial morbidity and mortality. Specific populations are at higher risk for exacerbations from influenza virus, such as patients with chronic obstructive pulmonary disease (COPD). Influenza vaccination coverage among COPD patients is low. Pharmacists can improve influenza vaccination among COPD patients by recognizing factors that influence vaccination and addressing these factors.

OBJECTIVES

To (1) determine the recent influenza vaccination coverage among patients with COPD, (2) identify factors that were associated with immunization, and (3) interpret the results based upon Andersen's healthcare utilization model.

METHODS

The 2012 Behavioral Risk Factor Surveillance System (BRFSS) was accessed for the study. Among respondents age ≥ 25 years with COPD, presence of influenza vaccination was captured along with demographic, provider, insurance, and clinical variables. Weighted multiple logistic regression was used to identify significant factors associated with receiving influenza vaccination. The findings were interpreted according to predisposing, enabling, and need factors relevant to Anderson's model.

RESULTS

Influenza vaccination rate was 53% among COPD patients. Older age was a significant predisposing factor that increased vaccination (adjusted odds ratio [AOR] = 2.4; 95% CI:2.02-2.88). Predisposing factors that decreased vaccination were being Black or Hispanic (AOR = 0.72, 95% CI:0.59-0.86, and AOR = 0.78, 95% CI:0.61-0.98 respectively), and being a non smoker (former and never smokers had higher vaccination rates [AOR = 1.53, 95% CI = 1.3-1.72, and AOR = 1.36, 95% CI = 1.19-1.55 respectively]). Significant enabling factors included having health insurance (AOR = 1.68, 95% CI = 1.37-2.06), a primary physician (AOR = 1.63, 95% CI = 1.30-2.02), and the ability to see a physician regardless of cost (AOR = 1.33, 95% CI = 1.17-1.52). Significant need factors included the presence of comorbidities such as asthma (AOR = 1.18, 95% CI = 1.1-1.3), or diabetes (AOR = 1.36, 95% CI = 1.20-1.53), activity limitation (AOR = 1.16, 95% CI = 1.04-1.29), and having the last medical checkup within less than one year (AOR = 1.49, 95% CI = 1.31-1.70).

CONCLUSION

Influenza vaccination coverage among COPD patients is far below the Healthy People 2020 national goal. Several predisposing, enabling, and need factors influenced vaccination rate among COPD patients. Pharmacists can improve vaccination rate among COPD patients by recognizing these influencing factors and by acting as advocates, counselors, and administrators of influenza vaccine. Ultimately, with the collaborative efforts of other healthcare providers and public health initiatives, pharmacists can help achieve Healthy People 2020 objectives related to influenza vaccination.

Authors+Show Affiliations

Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM, USA; Faculty of Pharmacy, Yarmouk University, P.O Box 566, Irbid 21163, Jordan. Electronic address: rasha.arabyat@yu.edu.jo.Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM, USA. Electronic address: draisch@salud.unm.edu.Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM, USA; Department of Family and Community Medicine, School of Medicine, University of New Mexico, Albuquerque, NM, USA. Electronic address: lbakhireva@salud.unm.edu.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

28533080

Citation

Arabyat, Rasha M., et al. "Influenza Vaccination for Patients With Chronic Obstructive Pulmonary Disease: Implications for Pharmacists." Research in Social & Administrative Pharmacy : RSAP, vol. 14, no. 2, 2018, pp. 162-169.
Arabyat RM, Raisch DW, Bakhireva L. Influenza vaccination for patients with chronic obstructive pulmonary disease: Implications for pharmacists. Res Social Adm Pharm. 2018;14(2):162-169.
Arabyat, R. M., Raisch, D. W., & Bakhireva, L. (2018). Influenza vaccination for patients with chronic obstructive pulmonary disease: Implications for pharmacists. Research in Social & Administrative Pharmacy : RSAP, 14(2), pp. 162-169. doi:10.1016/j.sapharm.2017.02.010.
Arabyat RM, Raisch DW, Bakhireva L. Influenza Vaccination for Patients With Chronic Obstructive Pulmonary Disease: Implications for Pharmacists. Res Social Adm Pharm. 2018;14(2):162-169. PubMed PMID: 28533080.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Influenza vaccination for patients with chronic obstructive pulmonary disease: Implications for pharmacists. AU - Arabyat,Rasha M, AU - Raisch,Dennis W, AU - Bakhireva,Ludmila, Y1 - 2017/02/24/ PY - 2017/02/13/received PY - 2017/02/13/accepted PY - 2017/5/24/pubmed PY - 2018/10/23/medline PY - 2017/5/24/entrez KW - Andersen's healthcare utilization model KW - Chronic obstructive pulmonary disorder (COPD) KW - Enabling factors KW - Influenza vaccination KW - Need factors KW - Pharmacists KW - Predisposing factors SP - 162 EP - 169 JF - Research in social & administrative pharmacy : RSAP JO - Res Social Adm Pharm VL - 14 IS - 2 N2 - BACKGROUND: Influenza virus is responsible for substantial morbidity and mortality. Specific populations are at higher risk for exacerbations from influenza virus, such as patients with chronic obstructive pulmonary disease (COPD). Influenza vaccination coverage among COPD patients is low. Pharmacists can improve influenza vaccination among COPD patients by recognizing factors that influence vaccination and addressing these factors. OBJECTIVES: To (1) determine the recent influenza vaccination coverage among patients with COPD, (2) identify factors that were associated with immunization, and (3) interpret the results based upon Andersen's healthcare utilization model. METHODS: The 2012 Behavioral Risk Factor Surveillance System (BRFSS) was accessed for the study. Among respondents age ≥ 25 years with COPD, presence of influenza vaccination was captured along with demographic, provider, insurance, and clinical variables. Weighted multiple logistic regression was used to identify significant factors associated with receiving influenza vaccination. The findings were interpreted according to predisposing, enabling, and need factors relevant to Anderson's model. RESULTS: Influenza vaccination rate was 53% among COPD patients. Older age was a significant predisposing factor that increased vaccination (adjusted odds ratio [AOR] = 2.4; 95% CI:2.02-2.88). Predisposing factors that decreased vaccination were being Black or Hispanic (AOR = 0.72, 95% CI:0.59-0.86, and AOR = 0.78, 95% CI:0.61-0.98 respectively), and being a non smoker (former and never smokers had higher vaccination rates [AOR = 1.53, 95% CI = 1.3-1.72, and AOR = 1.36, 95% CI = 1.19-1.55 respectively]). Significant enabling factors included having health insurance (AOR = 1.68, 95% CI = 1.37-2.06), a primary physician (AOR = 1.63, 95% CI = 1.30-2.02), and the ability to see a physician regardless of cost (AOR = 1.33, 95% CI = 1.17-1.52). Significant need factors included the presence of comorbidities such as asthma (AOR = 1.18, 95% CI = 1.1-1.3), or diabetes (AOR = 1.36, 95% CI = 1.20-1.53), activity limitation (AOR = 1.16, 95% CI = 1.04-1.29), and having the last medical checkup within less than one year (AOR = 1.49, 95% CI = 1.31-1.70). CONCLUSION: Influenza vaccination coverage among COPD patients is far below the Healthy People 2020 national goal. Several predisposing, enabling, and need factors influenced vaccination rate among COPD patients. Pharmacists can improve vaccination rate among COPD patients by recognizing these influencing factors and by acting as advocates, counselors, and administrators of influenza vaccine. Ultimately, with the collaborative efforts of other healthcare providers and public health initiatives, pharmacists can help achieve Healthy People 2020 objectives related to influenza vaccination. SN - 1934-8150 UR - https://www.unboundmedicine.com/medline/citation/28533080/Influenza_vaccination_for_patients_with_chronic_obstructive_pulmonary_disease:_Implications_for_pharmacists_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1551-7411(17)30090-6 DB - PRIME DP - Unbound Medicine ER -